Skip to main content
. 2015 Jul-Aug;9(7-8):242–247. doi: 10.5489/cuaj.2711

Table 2.

Distribution of adverse events

Adverse events SNM BonT-A OMT
Re-operation 8%
Device Infection 3%
Urinary tract infection 23% 12%
Xerostomia 16%
Blur 3%
Constipation 7%
Change device - lead 3%
Change device - IPG 3%
Risk of femoral neck fracture 8%

SNM: sacral-neuromodulation; BonT-A: botulinum-toxin-A; OMT: optimized medical-therapy; IPG: implanted pulse generator.